Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...

Air pollution contributes to Chronic Obstructive Pulmonary Disease (COPD) by exposing people to harmful substances, including fine particulate matter (PM2.5), nitrogen dioxide, and ozone. These ...

NEW YORK, NY – Nov. 19, 2025 – Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic sputum production and cough, claiming three ...

Dear Dr. Roach: I have hereditary hemochromatosis (HH) and atrial fibrillation. My AFib burden seems to vary with my iron levels. My AFib went from 58% to less than 2% in two weeks after I had a ...

DEAR DR. ROACH: I have hereditary hemochromatosis (HH) and atrial fibrillation. My AFib burden seems to vary with my iron levels. My AFib went from 58% to less than 2% in two weeks after I had a ...

Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre ® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade ...

Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade As ...

A research group from the National Cancer Research Centre (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult. A ...